PETALING JAYA: Amway (M) Bhd expects the prevailing challenging business environment to continue weighing on its revenue and profitability.
“Amid a challenging economic landscape in 2025, brought about by uncertainties in the global trade and tariff policies, weaker consumer demand and rising product costs driven by inflationary pressures, the group remains guided by our commitment to delivering shareholders’ value and our reputation as a trusted provider of health and well-being products,” Amway said in a filing with Bursa Malaysia.
It added that it would continue focusing on delivering holistic gut health solutions while adapting its business model to evolving consumer needs.
“In support of its long-term strategy, the group will continue to make targeted and prudent investments in several areas, including ABO (Amway business owner)-centric programmes, innovative product launches, health-centric communities, and essential infrastructure and technology upgrades,” it said.
In the first quarter ended March 31, Amway’s net profit tumbled 60% to RM13.2mil, down from RM32.7mil in the same quarter last year. The decline due to higher product costs, driven by increased purchase price and lower sales volume.
Revenue for the quarter fell to RM294.3mil against RM322mil previously, while earnings per share slid to 8.04 sen from 19.92 sen a year earlier.
Amway has announced a first single-tier interim dividend of five sen per share, payable on June 20.
